Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease-Reference-Cited by-同舟云学术

Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease

Published:2022-05 Issue:5 Volume:39 Page:110779
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Trieu Kenneth G.,Tsai Shih-Ying,Eberl Markus,Ju Virginia,Ford Noah C.,Doane Owen J.,Peterson Jamie K.,Veniaminova Natalia A.,Grachtchouk Marina,Harms Paul W.,Swartling Fredrik J.,Dlugosz Andrzej A.,Wong Sunny Y.

Funder

National Cancer Institute

Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania

LEO Fondet

American Cancer Society

National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference88 articles.

1. Patched1 and Patched2 redundancy plays a key role in regulating epidermal differentiation;Adolphe;J. Invest Dermatol.,2014

2. Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning;Ahn;Cell,2004

3. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice;Aszterbaum;Nat. Med.,1999

4. GLI activation by atypical protein kinase Cl/gamma regulates the growth of basal cell carcinomas;Atwood;Nature,2013

5. Smoothened variants explain the majority of drug resistance in basal cell carcinoma;Atwood;Cancer Cell,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity;Computational and Structural Biotechnology Journal;2024-12

2. Hedgehog pathway and cancer: A new area (Review);Oncology Reports;2024-07-10

3. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma;Expert Review of Clinical Pharmacology;2023-11-23

4. Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients;Cancers;2022-11-07

5. Multiple Basal Cell Carcinomas in Immunocompetent Patients;Cancers;2022-06-30